ENGINEERING CAR-T CELLS FOR IMPROVED FUNCTION AGAINST SOLID TUMORS

Engineering CAR-T Cells for Improved Function Against Solid Tumors

Genetic engineering T cells to create clinically applied chimeric antigen receptor (CAR) T cells has led to improved patient outcomes for some forms of hematopoietic malignancies.While this has inspired the biomedical community to develop similar strategies to treat solid tumor patients, challenges such as butterfly cupcake liners the immunosuppres

read more